EUVIMEDEUVIMED entdecken
Crossref

Prevalence of Hidradenitis Suppurativa in an African Population: Validation of a Screening Questionnaire in Lagos, Nigeria

Ehiaghe Lonia Anaba, Dorra Bouazzi, Pelumi Victor Ajayi, Oluwapelumi Olumide Aro, Jurr Boer, Gregor Borut Ernst Jemec

Dermatology · 2023

DOI: 10.1159/000531561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology, 2023. Verfasst von Ehiaghe Lonia Anaba und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Lagos State University College of Medicine, Lagos, Nigeria. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epidemiologic hidradenitis suppurativa (HS) studies from Africa are lacking. This study aimed at uncovering the prevalence of HS in Lagos, Nigeria, to validate an HS screening questionnaire, and to contribute to the Global Hidradenitis Suppurativa Atlas (GHiSA).

Methods

This was a cross-sectional study of 802 healthy adults accompanying their relations to the outpatient clinic of Family Medicine and Ophthalmology at the Lagos State University Teaching Hospital in Lagos, Nigeria, following ethical approval. Verbal and written consents were obtained prior to inclusion of study participants. The study was conducted using a validated screening questionnaire. Screen-positive and randomly selected screen-negative participants were clinically examined. Severity was categorized using the Hurley score.

Results

The prevalence of HS in the sample was 2.2% (18/802; 95% CI: 1.4–3.5%) with no gender predominance. The mean age in the HS group was 34 years (IQR 28–42) and the median body mass index (BMI) of the HS patients was 27.0 (IQR 21.4–28.6). There was no significant difference in BMI between the HS and control group. The screening questionnaire had a sensitivity of 1 (18/18), specificity of 0.8 (20/25), positive predictive value of 0.8 (18/23), and a negative predictive value of 1 (20/20). The axilla was the predominant site of affection (66.7%), and all HS patients were classified as mild disease (Hurley score 1).

Conclusion

The prevalence of HS in Lagos, Nigeria, was 2.2% and, in this population, BMI did not appear to be a risk factor. The axilla was the most affected site, and all patients had a mild disease severity (Hurley score 1). Finally, the HS screening questionnaire is a suitable tool in population surveys.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaAdultHumansPrevalenceNigeriaCross-Sectional StudiesSeverity of Illness Index

Stichwörter der Autor:innen

Acne inversaAfricaEpidemiologyHidradenitis suppurativaPrevalence

Autor:innen und Institutionen

  • Department of Medicine, Lagos State University College of Medicine, Lagos, Nigeria.
  • Department of Medicine, Lagos State University Teaching Hospital, Lagos, Nigeria.
  • Department of Dermatology, Zealand University Hospital, Roskilde, Denmark, dob@regionsjaelland.dk.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark, dob@regionsjaelland.dk.
  • Department of Dermatology, Deventer Hospital, Deventer, The Netherlands.
  • Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.

Zitieren

APA

Anaba, E. L., Bouazzi, D., Ajayi, P. V., Aro, O. O., Boer, J., & Jemec, G. B. E. (2023). Prevalence of Hidradenitis Suppurativa in an African Population: Validation of a Screening Questionnaire in Lagos, Nigeria. Dermatology. https://doi.org/10.1159/000531561

Vancouver

Anaba EL, Bouazzi D, Ajayi PV, Aro OO, Boer J, Jemec GBE. Prevalence of Hidradenitis Suppurativa in an African Population: Validation of a Screening Questionnaire in Lagos, Nigeria. Dermatology. 2023. doi:10.1159/000531561

BibTeX
@article{Anaba2023,
  author = {Anaba, Ehiaghe Lonia and Bouazzi, Dorra and Ajayi, Pelumi Victor and Aro, Oluwapelumi Olumide and Boer, Jurr and Jemec, Gregor Borut Ernst},
  title = {Prevalence of Hidradenitis Suppurativa in an African Population: Validation of a Screening Questionnaire in Lagos, Nigeria},
  journal = {Dermatology},
  year = {2023},
  doi = {10.1159/000531561}
}
Kostenlos starten →